Target
Mu-type opioid receptor
Ligand
BDBM50049563
Substrate
n/a
Meas. Tech.
ChEMBL_145270 (CHEMBL751207)
Ki
0.980000±n/a nM
Citation
 Bolognesi, MLOjala, WHGleason, WBGriffin, JFFarouz-Grant, FLarson, DLTakemori, AEPortoghese, PS Opioid antagonist activity of naltrexone-derived bivalent ligands: importance of a properly oriented molecular scaffold to guide"address" recognition at kappa opioid receptors. J Med Chem 39:1816-22 (1996) [PubMed]  Article 
Target
Name:
Mu-type opioid receptor
Synonyms:
M-OR-1 | MOR-1 | Mu opioid receptor | Mu-type opioid receptor (Mu) | OPIATE Mu | OPRM1 | OPRM_CAVPO
Type:
Enzyme Catalytic Domain
Mol. Mass.:
11165.58
Organism:
GUINEA PIG
Description:
P97266
Residue:
98
Sequence:
YTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKTVNVCNWI
  
Inhibitor
Name:
BDBM50049563
Synonyms:
5-amino-2,4(Bis-4-cyclopropylmethyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one) imidazole | CHEMBL299772
Type:
Small organic molecule
Emp. Form.:
C42H50N6O6
Mol. Mass.:
734.883
SMILES:
NC1=NC(=N[C@]11CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1C2(CCN3CC1CC1)c45)[C@]1(N)CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1C2(CCN3CC1CC1)c45 |c:3,t:1,TLB:24:23:8:28.12.11,49:48:33:53.37.36|
Structure:
Search PDB for entries with ligand similarity: